Valuation: Ganga Pharmaceuticals Limited

Market Cap 70.94M 739K 645K 597K 551K 1.04M 1.06M 7.11M 2.79M 34.74M 2.77M 2.71M 120M P/E 2024
349x
P/E 2025 84.8x
Enterprise Value 82.13M 855K 747K 691K 638K 1.2M 1.22M 8.24M 3.23M 40.21M 3.21M 3.14M 138M EV / Sales 2024
4.8x
EV / Sales 2025 2.29x
Free-Float
19.42%
Yield 2024 *
-
Yield 2025 -
05-21 Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2026 CI
03-10 Ganga Pharmaceuticals re-appoints Bharat Brijmohan Sharma as MD RE
11-07 Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2025 CI
25-07-01 Ganga Pharmaceuticals Limited Appoints Priti Bhaiya as Company Secretary and Compliance Officer, Effective July 01, 2025 CI
25-05-20 Ganga Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
25-04-22 Ganga Pharmaceuticals Limited Announces Resignation of Priti Kothari Bhaiya, Company Secretary and Compliance Officer of the Company Effective, April 22, 2025 CI
25-03-31 Ganga Pharmaceuticals Limited Announces Cessation of Chetan Bhikhubhai Patel and Sachin Chandrakant Chavan as Independent Directors and Member of the Board CI
24-11-08 Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2024 CI
24-05-16 Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
24-01-18 Ganga Pharmaceuticals Limited announced that it has received INR 17.0625 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp CI
23-12-03 Ganga Pharmaceuticals Limited announced that it expects to receive INR 21 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp CI
23-11-27 Ganga Pharmaceuticals Board to Consider Issuing Equity, Convertible Warrants to Raise Funds MT
23-11-08 Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
6 months+2.74%
Current year+2.74%
Current year 9.35
Extreme 9.35
13.97
1 year 9.35
Extreme 9.35
14.6
3 years 7.5
Extreme 7.5
28.49
5 years 5
Extreme 5
28.49
10 years 5
Extreme 5
28.49
Manager TitleAgeSince
Chief Executive Officer 62 1989-09-10
Director of Finance/CFO - 2018-09-05
Compliance Officer - 2016-03-21
Director TitleAgeSince
Director/Board Member 62 1989-09-10
Director/Board Member 60 2012-03-31
Chairman 72 2020-05-24
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-9.91%+15.38% 741K
-2.36%-6.53%+44.48%+156.95% 1,054B
-1.90%-5.45%+61.13%+58.05% 621B
-0.82%-3.66%+28.10%+80.38% 438B
-1.12%-3.68%+26.89%+20.58% 325B
-1.73%-3.45%+26.95%+44.09% 281B
-1.95%-13.92%+15.96%+19.76% 262B
-1.45%-2.37%-27.87%-39.87% 219B
-1.08%-3.13%+20.05%+56.78% 195B
-0.59%-4.23%+16.50%+69.18% 163B
Average -1.33%-1.53%+20.23%+48.13% 355.62B
Weighted average by Cap. -1.71%-1.69%+33.20%+77.18%

Financials

2024 2025
Net sales 27.36M 285K 249K 230K 213K 400K 408K 2.74M 1.08M 13.4M 1.07M 1.05M 46.13M 26.37M 275K 240K 222K 205K 386K 393K 2.65M 1.04M 12.91M 1.03M 1.01M 44.47M
Net income 466K 4.85K 4.24K 3.92K 3.62K 6.82K 6.95K 46.76K 18.35K 228K 18.23K 17.83K 786K 790K 8.23K 7.19K 6.65K 6.14K 11.56K 11.77K 79.26K 31.1K 387K 30.9K 30.22K 1.33M
Net Debt 13.28M 138K 121K 112K 103K 194K 198K 1.33M 523K 6.5M 519K 508K 22.39M 11.19M 116K 102K 94.1K 86.94K 164K 167K 1.12M 440K 5.48M 438K 428K 18.86M
Logo Ganga Pharmaceuticals Limited
Ganga Pharmaceuticals Limited is an India-based company. The Company is engaged in the production of ayurvedic medicine. Apart from manufacturing, the Company is also into marketing and distribution of ayurvedic medicines. It offers ayurvedic medicines for acidity, antidandruff, antioxidants, blood purifier and skin disorder, constipation, cough and cold, dental care, diarrhea, ear care, female tonic, hair care, hemorrhoids and piles, indigestion, iron tonic, joint pains, kidney stone, liver disorder, rejuvenation tonic, sleep inducers, and offers herbal cosmetics. Its products include Asuka tablets, Dendroil, Ashwo tablets-tonic for body and mind; Raktaj tablets/syrup for skin disorders; Nirmalaya that relieves constipation; Khadira tablets (80 mg.) that relieves cough; Danta Doshahar Manjan for gum and teeth protective; Holetrica capsule that checks diarrhea and corrects digestion; Karnaraj drops ear drops, Femoherb syrup/tablets, and Mahabhrungraj oil.
Employees
17
  1. Stock Market
  2. Stocks
  3. GANGAPHARM6 Stock